HAL (France)
open access
Does early disease progression predicts survival after first line-treatment of Waldenström macroglobulinemia?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1#1162669
- LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia#837535
- Clinico-pathologic characteristics, patterns of treatment and outcome of newly diagnosed Waldenstroms Macroglobulinemia- a single center real world retrospective analysis#180167
- Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia#903366
- A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia#865705
Record · ID 378090
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive